Study: Common Alzheimer's disease drug doubles hospitalization risk

Donepezil, a common Alzheimer's disease drug, is linked to a two-fold higher risk of hospital admission than other cholinesterase inhibitors, a Canadian medical study found Monday.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news